KPTI

Karyopharm Therapeutics Inc.

Company with tickers: KPTI

CIK

1503802

CUSIP

48576U205

Shares Outstanding

22,662,943

Website

https://www.karyopharm.com

Investor Relations

https://investors.karyopharm.com/

13F Activity (30d)

5 filings 4 filers

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard Paulson	CEO	$770,000	$100,100	$838,996	$241,544	$350,350	$19,912	$2,320,902
Reshma Rangwala	—	$567,736	$1,051,096	$79,492	$120,766	$178,837	$18,207	$2,016,134
Stuart Poulton	—	$500,135	$295,012	$312,293	$115,736	$157,543	$18,861	$1,399,580

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard Paulson	CEO	$769,600	—	$854,604	—	$425,425	$19,712	$2,069,341
Reshma Rangwala	—	$567,736	—	$315,794	—	$222,907	$18,007	$1,124,444
Sohanya Cheng	—	$546,000	—	$315,794	—	$214,373	$18,662	$1,094,829
Stuart Poulton	—	—	—	—	—	—	—	—

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard Paulson	CEO	$740,000	$200,000	$1,201,200	—	$456,950	$28,138	$2,626,288
Reshma Rangwala	—	$545,900	—	$450,465	—	$210,717	$20,707	$1,227,789
Sohanya Cheng	—	$513,688	—	$450,465	—	$202,650	$26,611	$1,193,414
Michael Mason	CFO	$500,320	—	$426,632	—	$191,623	$20,737	$1,139,312
Stuart Poulton	—	$477,000	—	$426,632	—	$184,122	$21,361	$1,109,115

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard Paulson	CEO	$696,800	$200,000	$2,982,788	$2,562,984	$452,920	$14,523	$6,910,015
Sharon Shacham	—	$211,934	—	$1,218,492	$3,414,984	$108,313	$1,084,066	$6,037,789
Michael Mason	CFO	$472,000	—	$1,062,906	$954,532	$193,048	$16,546	$2,699,032
Sohanya Cheng	—	$457,333	—	$1,019,520	$928,902	$193,048	$13,915	$2,612,718
Chief Commercial	—	$457,333	—	$1,019,520	$928,902	$193,048	$13,915	$2,612,718
Ran Frenkel	—	$279,375	—	$705,023	$640,746	—	$535,106	$2,160,250
Michael Mano	—	$427,333	—	$751,990	$683,342	$184,050	$13,692	$2,060,407
Chief Development	—	$373,910	$50,000	$580,100	$609,956	$168,713	$12,568	$1,795,247
Stuart Poulton	—	$373,910	$50,000	$580,100	$609,956	$153,314	$12,568	$1,779,848

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard Paulson	CEO	$468,365	$300,000	$3,523,008	$3,563,575	$435,500	$64,724	$8,355,172
Sharon Shacham	—	$499,905	—	$832,832	$1,507,217	$249,953	$16,684	$3,106,591
Michael Kauffman	—	$474,375	—	$832,832	$1,507,217	$237,188	$17,977	$3,069,589
Michael Mason	CFO	$444,386	$50,000	$370,834	$681,352	$182,000	$16,006	$1,744,578
Jatin Shah	—	$457,980	—	$320,509	$588,826	$179,078	$41,820	$1,588,213
Ran Frenkel	—	$429,525	$50,000	$320,509	$588,826	$172,000	$16,343	$1,577,203
Former Chief	—	$429,525	$50,000	$320,509	$588,826	$172,000	$16,343	$1,577,203

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Kauffman	CEO	$625,624	—	$1,029,886	$1,920,899	$348,750	$11,880	$3,937,039
Senior Clinical	CEO	$625,624	—	$1,029,886	$1,920,899	$348,750	$11,880	$3,937,039
Sharon Shacham	—	$483,624	—	$1,029,886	$1,920,899	$224,595	$11,880	$3,670,884
Former Chief	—	$483,624	—	$1,029,886	$1,920,899	$224,595	$11,880	$3,670,884
Chief Scientific	—	$483,624	—	$1,029,886	$1,920,899	$224,595	$11,880	$3,670,884
Michael Mason	CFO	$415,624	—	$586,963	$1,096,226	$156,123	$11,880	$2,266,816

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Kauffman	CEO	$566,500	—	$803,112	$1,486,339	$363,693	$11,860	$3,231,504
Senior Clinical	CEO	$566,500	—	$803,112	$1,486,339	$363,693	$11,860	$3,231,504
Sharon Shacham	—	$468,500	—	$803,112	$1,486,339	$250,648	$11,860	$3,020,459
Chief Scientific	—	$468,500	—	$803,112	$1,486,339	$250,648	$11,860	$3,020,459
Christopher Primiano	General Counsel	$418,200	—	$356,427	$660,881	$175,979	$11,860	$1,623,347
Michael Mason	CFO	$340,332	—	—	$529,935	$75,000	$11,430	$956,697

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Kauffman	CEO	$550,000	—	—	$1,444,660	$268,625	$11,660	$2,274,945
Sharon Shacham	—	$450,000	—	—	$1,444,660	$183,063	$11,660	$2,089,383
Christopher Primiano	General Counsel	$404,000	—	—	$902,913	$204,020	$11,660	$1,522,593

Executive changes

Person	Role	Change	Effective	Filed
Christy J. Oliger	Class I director	Appointed	—	2026-05-28
Barry E. Greene	Class I director	Appointed	—	2026-05-28